Christopher Hallemeier

Christopher Hallemeier is a radiation oncologist at Mayo Clinic who contributes to investigations of adjuvant chemoradiotherapy approaches in resected pancreatic cancer and has expertise in stereotactic radiation for locally advanced PDAC. His work addresses the ongoing debate regarding the role of adjuvant radiation in resected pancreatic cancer and integrates chemoradiation strategies with systemic FOLFIRINOX-based approaches. He contributes to RTOG and Alliance cooperative group trials examining radiation dose and fractionation in PDAC. Hallemeier works within a multidisciplinary pancreatic cancer team integrating surgical, radiation, and medical oncology perspectives.